Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ANI Pharmaceuticals Inc (NASDAQ:ANIP)

59.63
Delayed Data
As of 11:56am ET
 -1.02 / -1.68%
Today’s Change
26.80
Today|||52-Week Range
70.92
+32.14%
Year-to-Date
The Greatest Small-Cap Stocks You've Never Heard About
Dec 02 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close60.65
Today’s open61.84
Day’s range59.43 - 61.84
Volume62,917
Average volume (3 months)203,125
Market cap$703.0M
Dividend yield--
Data as of 11:56am ET, 12/05/2016

Growth & Valuation

Earnings growth (last year)-49.03%
Earnings growth (this year)+49.14%
Earnings growth (next 5 years)+18.20%
Revenue growth (last year)+36.36%
P/E ratio87.7
Price/Sales6.83
Price/Book4.36

Competitors

 Today’s
change
Today’s
% change
MYOVMyovant Sciences Ltd-0.14-1.24%
BPMCBlueprint Medicines ...+1.24+4.59%
RTRXRetrophin Inc+0.59+2.93%
CRSPCRISPR Therapeutics ...+1.24+6.52%
Data as of 12:00pm ET, 12/05/2016

Financials

Next reporting dateFebruary 28, 2017
EPS forecast (this quarter)$1.10
Annual revenue (last year)$76.3M
Annual profit (last year)$15.3M
Net profit margin20.03%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Arthur S. Przybyl
Vice President-
Operations
James G. Marken
Corporate headquarters
Baudette, Minnesota

Forecasts


Search for Jobs